CLINICAL_TRIALS
trial_result
· 2020-12-10
Clinical Trial Update: PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK [Phase 4]
Summary
Phase 4 clinical trial update for Luxerm® in actinic keratoses shows completed study with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Actinic Keratoses | Phase 4 | Status: COMPLETED | Results posted: 2020-12-10